Macromolecular Research, Vol.19, No.1, 38-43, January, 2011
Particle Size Reduction of Water-Insoluble Drug in Water-Assisted Extrusion of Hydroxypropyl Methyl Cellulose
E-mail:
Recent advances in the preparation of nanoparticles of water-insoluble drugs, while remarkable, still largely require a secondary drying step to produce solid dosage forms. This report describes the novel extrusion of crystalline drug particles in a polymer/water matrix, which was developed as a comminution technique for particle size reduction. Itraconazole and hydroxypropyl methyl cellulose were used as a model drug and a matrix polymer, respectively. Nanocomposites of 400 nm itraconazole crystals were prepared successfully with significantly improved release kinetics. The water and polymer content should be optimized, and the repeated extrusion runs were
beneficial for effective particle size reduction. This process produced nanocomposite granules, containing stable crystalline drug particles, which can be processed readily into a solid dosage form with a high drug content without a drying step.
Keywords:hydroxypropyl methyl cellulose;drug nanoparticles;itraconazole;hot melt extrusion;granules;waterinsoluble drugs.
- Merisko-Liversidge E, Liversidge GG, Cooper ER, Eur. J. Pharm. Sci., 18, 113 (2003)
- Miller DA, McConville JT, Yang W, Iii ROW, McGinity JW, J. Pharm. Sci., 96, 361 (2006)
- Muller RH, Peters K, Int. J. Pharm., 160, 229 (1998)
- Chattopadhyay P, Gupta RB, Int. J. Pharm., 228, 19 (2001)
- Rasenack N, Muller BW, Pharm. Dev. Technol., 9, 1 (2004)
- Bleich J, Muller BW, J. Microencapsul., 13(2), 131 (1996)
- Ghaderi R, Artursson P, Carlfors J, Pharm. Res., 16, 676 (1999)
- Hu J, Johnston KP, Williams RO, Drug Dev. Ind. Pharm., 30, 233 (2004)
- Palakodaty S, York P, Pharm. Res., 16, 976 (1999)
- Phillips EM, Stella VJ, Int. J. Pharm., 94, 1 (1993)
- Reverchon E, J. Supercrit. Fluids, 15(1), 1 (1999)
- Rogers TL, Johnston KP, Williams RO, Drug Dev. Ind. Pharm., 27, 1003 (2001)
- Shah NH, Phuapradit W, Bachynsky M, Infeld MH, Iqbal K, Malick AW, Drug Dev. Ind. Pharm., 20, 873 (1994)
- Chen X, Young TJ, Sarkari M, Williams RO, Int. J. Pharm., 242, 3 (2002)
- Lee J, Lee SJ, Choi JY, Yoo JY, Ahn CH, Eur. J. Pharm. Sci., 24, 441 (2005)
- Lee J, Cheng Y, J. Control. Release, 111, 185 (2006)
- Lee J, J. Pharm. Sci., 92, 2057 (2003)
- Breitenbach J, Eur. J. Pharm. Biopharm., 54, 107 (2002)
- Fukuda M, Miller DA, Peppas NA, McGinity JW, Int. J. Pharm., 350, 188 (2008)
- Ozguney I, Shuwisitkul D, Bodmeier R, Eur. J. Pharm. Biopharm., 73, 140 (2009)
- Crowley MM, Zhang F, Repka MA, Thumma S, Upadhye SB, Kumar S, McGinity JW, Martin C, Drug Dev. Ind. Pharm., 33, 909 (2007)
- Thompson MR, Sun J, J. Pharm. Sci., 99, 2090 (2009)
- Medina C, Daurio D, Nagapudi K, Alvarez-Nunez F, J. Pharm. Sci., 99, 1693 (2009)
- Dukic-Ott A, Remon JP, Foreman P, Vervaet C, Eur. J. Pharm. Biopharm., 67, 715 (2007)
- Tomer G, Podczeck F, Newton JM, Int. J. Pharm., 217, 237 (2001)
- Repka MA, Battu SK, Upadhye SB, Thumma S, Crowley MM, Zhang F, Martin C, McGinity JW, Drug Dev. Ind. Pharm., 33, 1043 (2007)
- Tao T, Zhao Y, Wu J, Zhou B, Int. J. Pharm., 367, 109 (2009)
- Choi JY, Yoo JY, Kwak HS, Nam BU, Lee J, Curr. Appl. Phys., 5(5), 472 (2005)
- Chiche D, Digne M, Revel R, Chaneac C, Jolivet JP, J. Phys. Chem. C, 112, 8524 (2008)
- Kim JK, Park JS, Kim CK, Int. J. Pharm., 383, 209 (2009)
- Kendall K, Nature, 272, 710 (1978)